CoChat

Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels

Open access
Hebert, Patricia R., Bolt, Robert J., Borhani, Nemat O., Cook, Nancy R., Cohen, Jerome D., Cutler, Jeffrey A., Hollis, Jack F., Kuller, Lewis H., Lasser, Norman L., Oberman, Albert, Miller, Stephen T., Morris, Cynthia, Whelton, Paul K., Hennekens, Charles H. · 1995 · Annals of Epidemiology
Cited by 62

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Phase II of the Trials of Hypertension Prevention (TOHP) is a multicenter, randomized trial sponsored by the National Heart, Lung, and Blood Institute designed to test whether weight loss alone, sodium reduction alone, or the combination of weight loss and sodium reduction will decrease diastolic (DBP) and systolic blood pressure (SBP) as well as the incidence of hypertension (DBP > or = 90 mm Hg, SBP > or = 140 mm Hg, and/or use of antihypertensive medications) in subjects with high-normal DBP (83 to 89 mm Hg) and SBP less than 140 mm Hg at entry. These interventions were chosen for longer-term testing with end points including hypertension prevention as well as blood pressure (BP) change based on their demonstrated short-term efficacy in reducing BP in phase I of TOHP. The phase II study population is comprised of 2382 participants (1566 men and 816 women) who are 110 to 165% of desirable body weight, allocated at random to the four treatment arms using a 2 x 2 factorial design. The trial has 80% power to detect an overall treatment effect on DBP of 1.2 mm Hg for weight loss or sodium reduction and a difference of 1.6 mm Hg between the combined intervention and placebo groups. BP observers are blinded to participant treatment assignments. Participants will be followed for 3 to 4 years. This trial may have important public policy implications concerning the ability of life-style modifications to reduce BP and prevent the development of hypertension over the long term, thereby avoiding the need for drug therapy which while effective is costly and may have side effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/1047-2797(94)00057-z

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 62

Metadata

Authors
Hebert, P. R., Bolt, R. J., Borhani, N. O., Cook, N. R., Cohen, J. D., Cutler, J. A., Hollis, J. F., Kuller, L. H., Lasser, N. L., Oberman, A., Miller, S. T., Morris, C., Whelton, P. K., & Hennekens, C. H.
Venue
Annals of Epidemiology
Publisher
Elsevier BV
Published
1995-03
Volume
5
Issue
2
Pages
130-139
ISSN
1047-2797 (ISSN-L)
OpenAlex
W1990526703
Cited by
62
References
1
FWCI
3.25
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. https://app.cochat.ai/papers/10.1016/1047-2797(94)00057-z
The paper
Hebert, P. R., Bolt, R. J., Borhani, N. O., Cook, N. R., Cohen, J. D., Cutler, J. A., Hollis, J. F., Kuller, L. H., Lasser, N. L., Oberman, A., Miller, S. T., Morris, C., Whelton, P. K., & Hennekens, C. H. (1995). Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Annals of Epidemiology. https://doi.org/10.1016/1047-2797(94)00057-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.